Results 81 to 90 of about 2,196,135 (231)

Current insights into drug-coated balloons for peripheral arterial disease

open access: yes
Introduction: Peripheral artery disease (PAD) is a manifestation of systemic atherosclerosis. It is often associated with coronary and/or cerebral vascular involvement, leading to a higher risk of cardiovascular and cerebrovascular events, among which ...
Virga V   +7 more
core   +1 more source

Drug-coated balloon angioplasty for severe pulmonary vein stenosis resulting from cryoballoon ablation for atrial fibrillation

open access: yes, 2022
We performed a drug-coated balloon (DCB) angioplasty for severe pulmonary vein (PV) stenosis resulting from cryoballoon ablation for atrial fibrillation. Three and fourteen months after the angioplasty, follow-up multidetector computed tomography did not
Soeki, Takeshi   +12 more
core   +1 more source

Drug-Coated Balloon Treatment for Urethral Strictures: Is This the Future? A Review of the Current Literature

open access: yesJournal of Clinical Medicine
Urethral strictures significantly impact patients’ quality of life, with endoscopic treatments such as direct vision internal urethrotomy (DVIU) and dilatation showing high recurrence rates.
K. Kapriniotis   +4 more
semanticscholar   +1 more source

A Review on Recent Trends of Bioinspired Soft Robotics: Actuators, Control Methods, Materials Selection, Sensors, Challenges, and Future Prospects

open access: yesAdvanced Intelligent Systems, Volume 7, Issue 3, March 2025.
This article reviews the current state of bioinspired soft robotics. The article discusses soft actuators, soft sensors, materials selection, and control methods used in bioinspired soft robotics. It also highlights the challenges and future prospects of this field.
Abhirup Sarker   +2 more
wiley   +1 more source

Drug‐Coated Balloon Versus Drug‐Eluting Stent for De Novo Lesions of Large Coronary Arteries: A Systematic Review and Meta‐Analysis of Angiographic and Clinical Outcomes

open access: yesCatheterization and cardiovascular interventions
Efficacy of drug‐coated balloons (DCBs) has been established in the treatment of in‐stent restenosis and small vessel coronary artery disease, while utility in large‐vessel de novo lesions remains controversial.
Ahmed Hassan   +9 more
semanticscholar   +1 more source

Animal stroke models and outcome evaluation: A review

open access: yesAnimal Models and Experimental Medicine, EarlyView.
Rodents are the preeminent stroke model species. Large animal models exist too, but are poorly standardized. Ischemic and hemorrhagic experimental models are available, with the intraluminal filament model being predominant. Outcomes are evaluated via quantifying subjects' sensorimotor impairment, cognitive memory faculties, degree of cellular ...
Solsa Cariba   +2 more
wiley   +1 more source

Long-Term Outcomes of Recurrent Bulbar Urethral Stricture Treatment With the Optilume Drug-Coated Balloon: Five-Year Results From the ROBUST I Study

open access: yesJournal of Urology
Purpose: We report the 5-year study closeout results for the ROBUST I trial evaluating the safety and efficacy of the Optilume drug-coated balloon (DCB) for men with short, recurrent bulbar urethral strictures.
J. DeLong   +6 more
semanticscholar   +1 more source

The processes of reform in Victoria’s alcohol and other drug sector, 2011-2014 [PDF]

open access: yes, 2014
This paper explores issues and concerns related to the 2014 alcohol and other drug sector recommissioning process in Victoria. Overview In mid-2014, the Victorian Alcohol and Drug Association approached the Drug Policy Modelling Program, at the ...
Drug Policy Modelling Program
core  

Bioabsorbable Endovascular Adhesive Tape (BEAT) for Improving Vascular Regeneration

open access: yesAdvanced Science
The drug‐coated balloons (DCBs) provide a combination therapy of balloon angioplasty and anti‐proliferative drug delivery to target lesions, thereby facilitating the appealing concept of leaving nothing behind.
Jiarong Wang   +13 more
doaj   +1 more source

Drug‐Coated Balloon‐Based Strategy for De Novo Coronary Artery Disease Across Complex and High‐Risk Indicated Percutaneous Coronary Intervention Risk Categories: A Multicenter Registry Study

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Evidence regarding the risk‐stratified effectiveness of drug‐coated balloon (DCB)‐based PCI for de novo coronary artery disease (CAD) remains limited, particularly in patients undergoing complex and high‐risk indicated percutaneous coronary intervention (CHIP PCI).
Dong Oh Kang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy